This new initiative is focused on using behavioral measures and computational methods to define novel clinical signatures that can be used for individual-level prediction and clinical decision making in treating mental disorders. The importance of this new NIMH program was highlighted in a recent news update issued by the White House Office of Science and Technology. This study, titled, “Phenotypes REimagined to Define Clinical Treatment and Outcome Research (PREDiCTOR)”, will use objective, scalable, and cost-effective measurements to define novel clinical signatures that can be used for individual-level prediction and clinical decision-making in treating mental health disorders. Join us in exploring innovative approaches to intelligence, where AI and human cognition converge to tackle pressing issues in healthcare and beyond.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Entry Level
Education Level
Ph.D. or professional degree